Phase 2 Clinical Trial of ONC201 in Patients with Glioma that has H3 K27M Mutation 

Phase 2 Clinical Trial of ONC201 in Patients with Glioma that has H3 K27M Mutation 

Cancer-News

2 years
320 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Andrew Chi, MD, PhD at NYU Langone Medical Center Explains Phase 2 Clinical Trial of ONC201 in Patients with Glioma that has H3 K27M Mutation. Clinical Trial: ONC201 in Adults With Recurrent H3 K27M High-grade Glioma.
Up Next Autoplay